79 related articles for article (PubMed ID: 7027060)
1. Circulating immune complexes in patients with melanoma.
Sztaba-Kania M; Jassem J; Piskorzyńska M; Kondrat W
Neoplasma; 1981; 28(4):491-6. PubMed ID: 7027060
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes in patients with lymphomas and leukemias.
Patel GV; Gopal R; Nadkarni JJ
Neoplasma; 1984; 31(2):197-202. PubMed ID: 6585680
[TBL] [Abstract][Full Text] [Related]
3. [Appearance of circulating immune complexes in patients with Hodgkin's disease and the etiology of this disease].
Dziewulska-Bokiniec A; Sztaba-Kania M
Wiad Lek; 1992 Oct; 45(19-20):740-3. PubMed ID: 1296377
[TBL] [Abstract][Full Text] [Related]
4. The nature of immune complexes in human cancer sera.
Theofilopoulos AN; Andrews BS; Urist MM; Morton DL; Dixon FJ
J Immunol; 1977 Aug; 119(2):657-63. PubMed ID: 886189
[TBL] [Abstract][Full Text] [Related]
5. Reversible inhibition of mononuclear cell Fc receptors by sera from breast cancer patients.
Cillari E; Lio D; Salerno A
J Clin Lab Immunol; 1984 May; 14(1):23-7. PubMed ID: 6235370
[TBL] [Abstract][Full Text] [Related]
6. [Immune complexes in neoplastic diseases and autoimmune processes].
Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG; Vygovskaia IaI; Zakharchuk LS
Vopr Onkol; 1983; 29(8):3-7. PubMed ID: 6613066
[TBL] [Abstract][Full Text] [Related]
7. Immune-complexes in malignant skin melanoma: quantitation by three methods, purification, and characterization of their non-tumor related constituents.
Borzini P; Del Giudice G; Natali S; Serino G; Nembri P; Manca F; Zanussi C
Boll Ist Sieroter Milan; 1980 Sep; 59(4):366-73. PubMed ID: 7470278
[TBL] [Abstract][Full Text] [Related]
8. Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes.
Vlock DR; Kirkwood JM
J Clin Invest; 1985 Aug; 76(2):849-54. PubMed ID: 3875634
[TBL] [Abstract][Full Text] [Related]
9. TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma.
Hsueh EC; Gupta RK; Qi K; Yee R; Leopoldo ZC; Morton DL
Cancer J Sci Am; 1997; 3(6):364-70. PubMed ID: 9403050
[TBL] [Abstract][Full Text] [Related]
10. Circulating melanoma-associated antigens in ocular melanoma.
Whitmore WG; Witkin SS; Ellsworth RM
Ann Ophthalmol; 1988 Jun; 20(6):212-7. PubMed ID: 3408088
[TBL] [Abstract][Full Text] [Related]
11. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of assays to detect immune complexes as an immunodiagnostic aid in patients with melanoma.
Ruell P; Murray E; McCarthy WH; Hersey P
Oncodev Biol Med; 1982; 3(1):1-12. PubMed ID: 6981802
[TBL] [Abstract][Full Text] [Related]
14. Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant.
McCaffery M; Yao TJ; Williams L; Livingston PO; Houghton AN; Chapman PB
Clin Cancer Res; 1996 Apr; 2(4):679-86. PubMed ID: 9816218
[TBL] [Abstract][Full Text] [Related]
15. [Immune complexes as markers in breast cancer and melanoma].
Cappellari A; Corradi G
Boll Ist Sieroter Milan; 1987; 66(4):303-7. PubMed ID: 3442620
[TBL] [Abstract][Full Text] [Related]
16. Immune complexes in the serum of hamsters with transplanted melanomas.
Kozłowska K; Zurawska-Czupa B; Kostulak A
Neoplasma; 1986; 33(4):431-6. PubMed ID: 3762805
[TBL] [Abstract][Full Text] [Related]
17. Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma.
van Houdt IS; Oudejans JJ; van den Eertwegh AJ; Baars A; Vos W; Bladergroen BA; Rimoldi D; Muris JJ; Hooijberg E; Gundy CM; Meijer CJ; Kummer JA
Clin Cancer Res; 2005 Sep; 11(17):6400-7. PubMed ID: 16144945
[TBL] [Abstract][Full Text] [Related]
18. Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: correlation with clinical response.
Ahn SS; Irie RF; Weisenburger TH; Jones PC; Juillard G; Roe DJ; Morton DL
Surgery; 1982 Aug; 92(2):362-7. PubMed ID: 7101129
[TBL] [Abstract][Full Text] [Related]
19. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma.
Nicholaou T; Ebert LM; Davis ID; McArthur GA; Jackson H; Dimopoulos N; Tan B; Maraskovsky E; Miloradovic L; Hopkins W; Pan L; Venhaus R; Hoffman EW; Chen W; Cebon J
Clin Cancer Res; 2009 Mar; 15(6):2166-73. PubMed ID: 19276262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
